Related Experiment Video
Updated: Jun 13, 2026
09:32
Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
Atopic dermatitis in children: what to do when nothing works
1Department of Dermatology, Berufsgenossenschaftliches Unfallkrankenhaus Hamburg Hamburg, Germany.
Summary
Pediatric atopic eczema treatment requires regular emollient and anti-inflammatory use. If treatment fails, focus on patient education and environmental trigger elimination before considering systemic immunosuppression.
Area of Science:
- Dermatology
- Pediatrics
- Allergology
Background:
- Atopic eczema is a common childhood skin condition.
- Standard management includes emollients, topical anti-inflammatories, education, and trigger avoidance.
- Treatment failure can be distressing for families.
Purpose of the Study:
- To review common causes of treatment failure in childhood atopic eczema.
- To provide strategies for managing treatment-resistant cases.
- To emphasize the importance of adherence and environmental control.
Main Methods:
- Literature review of treatment strategies for atopic eczema.
- Analysis of factors contributing to treatment non-response.
- Discussion of alternative and advanced treatment options.
Main Results:
- Non-compliance and unaddressed environmental triggers are primary reasons for treatment failure.
- Parental education and reassurance are crucial for successful management.
- Systemic immunosuppression is reserved for severe, refractory cases after exhausting other options.
Conclusions:
- Optimizing adherence and eliminating triggers are key to successful atopic eczema management.
- A structured educational approach empowers parents to manage the condition effectively.
- Systemic therapies should be a last resort in pediatric atopic eczema treatment.
Related Concept Videos
01:27Acne Infection
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
02:06Allergic Reactions
Overview